Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It

Cong Chen1, Qianwei Ye1, Linbo Wang2

  • 1Department of Breast Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Cell Death Discovery
|February 23, 2023
PubMed

Insights

Pyroptosis, a programmed cell death involving Gasdermin proteins, is implicated in tumor development. Targeting pyroptosis offers a novel therapeutic strategy for breast cancer treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Pyroptosis is a lytic, inflammatory programmed cell death pathway.
  • Gasdermin proteins (GSDMs) mediate pyroptosis.
  • Emerging evidence links pyroptosis to tumor development and cancer therapy.

Purpose of the Study:

  • To provide foundational knowledge of pyroptosis.
  • To review GSDM expression and roles in breast cancer.
  • To explore pyroptosis's clinical potential in breast cancer treatment.

Main Methods:

  • Literature review of pyroptosis mechanisms.
  • Analysis of GSDM expression patterns in breast cancer.
  • Synthesis of evidence on pyroptosis in breast cancer progression.

Main Results:

  • GSDMs play significant roles in breast cancer.
  • Pyroptosis is involved in breast cancer progression.
  • Pyroptosis modulation presents a potential therapeutic avenue.

Conclusions:

  • Understanding pyroptosis deepens insights into breast cancer.
  • Targeting pyroptosis offers a novel strategy for breast cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K